BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh G, Song S, Choi E, Lee PB, Nahm FS. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia. Korean J Pain 2020;33:201-7. [PMID: 32606264 DOI: 10.3344/kjp.2020.33.3.201] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Kim J, Cheun H, Jeong J, Lee HJ. Bibliometric analysis of research articles on post-herpetic neuralgia published from 1991 to 2020. Medicine (Baltimore) 2023;102:e32967. [PMID: 36820531 DOI: 10.1097/MD.0000000000032967] [Reference Citation Analysis]
2 Kim SH. Current scenario and future applicability of antivirals against herpes zoster. Korean J Pain 2023;36:4-10. [PMID: 36573010 DOI: 10.3344/kjp.22391] [Reference Citation Analysis]
3 Moyad MA. Adult preventive vaccines with other synergistic lifestyle options: is it time to add these ancillary benefits to the overall AS management checklist? World J Urol 2021. [PMID: 33963444 DOI: 10.1007/s00345-021-03709-2] [Reference Citation Analysis]
4 Gebre MS, Brito LA, Tostanoski LH, Edwards DK, Carfi A, Barouch DH. Novel approaches for vaccine development. Cell 2021;184:1589-603. [PMID: 33740454 DOI: 10.1016/j.cell.2021.02.030] [Cited by in Crossref: 64] [Cited by in F6Publishing: 44] [Article Influence: 32.0] [Reference Citation Analysis]